St. John’s Wort does appear to help with mild to moderate depression, performing better than placebo in most clinical trials and roughly matching standard antidepressants for that severity range. But the picture gets more complicated with moderate-to-severe depression, and the supplement carries real risks that are easy to overlook because it’s sold over the counter.
What the Evidence Actually Shows
A large meta-analysis pooling over 2,100 participants found that about 53% of people taking St. John’s Wort responded to treatment, compared to roughly 33% on placebo. That’s a meaningful gap. For every four or five people who tried the supplement, one experienced improvement they wouldn’t have gotten from a sugar pill.
When researchers narrowed the analysis to mild and moderate depression specifically, St. John’s Wort slightly outperformed standard antidepressants, with response rates of about 60% versus 53%. A broader 2008 review of 29 international studies reached a similar conclusion: for mild to moderate depression, the herb was better than placebo and roughly as effective as prescription antidepressants.
The story changes for more severe depression. A well-known trial of 340 participants funded by the National Institutes of Health found St. John’s Wort no more effective than placebo for major depression of moderate severity. Another 26-week trial with 124 participants found that St. John’s Wort, the SSRI sertraline, and placebo all performed similarly for moderate major depression. So the supplement’s sweet spot is genuinely mild to moderate symptoms, not the kind of depression that makes it hard to function day to day.
How It Works in the Brain
St. John’s Wort acts on the same brain chemicals that prescription antidepressants target. It inhibits the reuptake of serotonin, dopamine, and norepinephrine, meaning it keeps more of these mood-regulating chemicals available at the connections between nerve cells. It also appears to block an enzyme that breaks down norepinephrine, further boosting levels. This triple action is actually broader than most SSRIs, which primarily affect serotonin alone.
The plant contains several active compounds, but two get the most attention. Hypericin is the one most extracts are standardized around. Hyperforin is believed to be the primary driver of both antidepressant effects and, unfortunately, most of the drug interactions.
How It Compares to SSRIs
Multiple systematic reviews agree: for mild to moderate depression, there is no significant difference in effectiveness between St. John’s Wort and SSRIs like fluoxetine or sertraline. One subgroup analysis of a double-blind trial found St. John’s Wort actually outperformed the SSRI paroxetine in patients with moderate depression after six weeks, though that’s a single finding rather than a pattern.
Where the supplement consistently wins is side effects. People taking St. John’s Wort report fewer gastrointestinal and neurological side effects than those on conventional antidepressants. This translates directly into lower dropout rates. Fewer people quit treatment because they can’t tolerate it, which matters because an antidepressant only works if you keep taking it. Both tricyclic antidepressants and SSRIs have higher discontinuation rates due to side effects compared to St. John’s Wort.
Typical Dosage and Timeline
Most clinical trials use 300 mg of St. John’s Wort extract taken three times daily, for a total of 900 mg per day. The extract is typically standardized to contain 0.3% hypericin, which comes out to about 0.9 mg of hypericin across the three doses. This standardization matters because the active compound levels in unstandardized products can vary wildly.
You should expect to wait 4 to 6 weeks before noticing meaningful improvement, similar to the timeline for prescription antidepressants. If you haven’t noticed a change after six weeks, it’s reasonable to consider other options rather than continuing to wait.
Drug Interactions Are the Biggest Risk
This is where St. John’s Wort gets genuinely dangerous, and it’s the main reason many doctors are cautious about recommending it. Hyperforin activates a receptor in the liver that ramps up production of a key enzyme responsible for metabolizing a huge number of medications. When this enzyme is overactive, it breaks down other drugs faster than intended, making them less effective or even useless.
The list of affected medications is long and includes some where reduced effectiveness can be life-threatening:
- Birth control pills: St. John’s Wort can reduce the effectiveness of hormonal contraceptives, leading to unintended pregnancy.
- Blood thinners: Faster metabolism can drop levels below the therapeutic range, increasing clotting risk.
- HIV medications: Clinical studies have shown that the antiretroviral indinavir is significantly affected.
- Organ transplant drugs: Cyclosporin, used to prevent organ rejection, can drop to dangerously low levels.
If you take any prescription medication, this interaction profile is not something to guess about. The enzyme St. John’s Wort activates is involved in processing roughly half of all commonly used drugs.
Serotonin Syndrome With Antidepressants
Combining St. John’s Wort with SSRIs creates a separate, more immediate danger. Because both raise serotonin levels, taking them together can push serotonin high enough to trigger serotonin syndrome, a potentially life-threatening condition. Symptoms include agitation, rapid heart rate, high body temperature, muscle twitching, and in severe cases, seizures.
Case reports have most commonly involved sertraline and paroxetine as the SSRIs in these combinations. This is particularly risky because someone might start taking St. John’s Wort while already on an SSRI, thinking a “natural” supplement is safe to add. It is not. St. John’s Wort and SSRIs should not be taken together.
It’s a Supplement, Not a Medication
In the United States, St. John’s Wort is sold as a dietary supplement, not an FDA-approved medication. This distinction matters practically. Manufacturers are responsible for evaluating their own products’ safety and labeling before selling them. The FDA does not test or approve supplements before they reach store shelves, and it can only intervene after a public health concern arises. This means the quality, potency, and purity of St. John’s Wort products can vary between brands. In Germany, by contrast, health authorities have formally approved St. John’s Wort as a treatment for mild to moderate depression, and products there are held to pharmaceutical standards.
If you choose to try St. John’s Wort, look for products standardized to 0.3% hypericin from established supplement brands, and be especially careful about interactions with any other medications you take. The evidence supports that it works for milder forms of depression, but “natural” does not mean “without risk.”